Sartorius Stedim Financials
| 56S1 Stock | EUR 183.30 1.10 0.60% |
Sartorius |
Understanding current and past Sartorius Stedim Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sartorius Stedim's financial statements are interrelated, with each one affecting the others. For example, an increase in Sartorius Stedim's assets may result in an increase in income on the income statement.
Sartorius Stedim Stock Summary
Sartorius Stedim competes with CompuGroup Medical, Siamgas, SCANDMEDICAL SOLDK, Avanos Medical, and China BlueChemical. Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. SARTOR STED operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8200 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | FR0013154002 |
| Business Address | Zone Industrielle Les |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.sartorius.com |
| Phone | 33 4 42 84 56 00 |
| Currency | EUR - Euro |
You should never invest in Sartorius Stedim without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Sartorius Stock, because this is throwing your money away. Analyzing the key information contained in Sartorius Stedim's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Sartorius Stedim Key Financial Ratios
There are many critical financial ratios that Sartorius Stedim's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Sartorius Stedim Biotech reports annually and quarterly.| Return On Equity | 0.41 | |||
| Return On Asset | 0.15 | |||
| Beta | 0.45 | |||
| Z Score | 16.2 | |||
| Last Dividend Paid | 1.44 |
Sartorius Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sartorius Stedim's current stock value. Our valuation model uses many indicators to compare Sartorius Stedim value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sartorius Stedim competition to find correlations between indicators driving Sartorius Stedim's intrinsic value. More Info.Sartorius Stedim Biotech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.37 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sartorius Stedim Biotech is roughly 2.68 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sartorius Stedim's earnings, one of the primary drivers of an investment's value.Sartorius Stedim Biotech Systematic Risk
Sartorius Stedim's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sartorius Stedim volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Sartorius Stedim Biotech correlated with the market. If Beta is less than 0 Sartorius Stedim generally moves in the opposite direction as compared to the market. If Sartorius Stedim Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sartorius Stedim Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sartorius Stedim is generally in the same direction as the market. If Beta > 1 Sartorius Stedim moves generally in the same direction as, but more than the movement of the benchmark.
Sartorius Stedim December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sartorius Stedim help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sartorius Stedim Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sartorius Stedim Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Sartorius Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sartorius Stedim's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.41 | |||
| Information Ratio | 0.0144 | |||
| Maximum Drawdown | 26.99 | |||
| Value At Risk | (4.37) | |||
| Potential Upside | 4.2 |
Complementary Tools for Sartorius Stock analysis
When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |